A phase I clinical trial to assess the tolerability, pharmacokinetics and pharmacodynamics of single and multiple ascending doses of PRX 167700 in healthy male subjects.
Phase of Trial: Phase I
Latest Information Update: 02 Mar 2012
At a glance
- Drugs PRX 167700 (Primary)
- Indications Psoriasis; Rheumatoid arthritis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 02 Mar 2012 New trial record